Table 3. Comparison of the cases with or without access site-related bleeding complications in TFA-TACE group.
| Patient characteristics | Cases with complications (n=9) | Cases without complications (n=154) | P value |
|---|---|---|---|
| Age, years | 72.6±7.9 | 57.1±12.7 | <0.001* |
| Sex, n (%) | 1.000 | ||
| Male | 7 (77.8) | 118 (76.6) | |
| Female | 2 (22.2) | 36 (23.4) | |
| Height, m | 1.66±0.05 | 1.68±0.06 | 0.385 |
| BMI, kg/m2 | 22.87±2.20 | 22.25±2.59 | 0.480 |
| Hypertension, n (%) | 1.000 | ||
| Yes | 4 (44.4) | 61 (39.6) | |
| No | 5 (55.6) | 93 (60.4) | |
| Diabetes mellitus, n (%) | 0.563 | ||
| Yes | 3 (33.3) | 30 (19.5) | |
| No | 6 (66.7) | 124 (80.5) | |
| Previously TACE, n (%) | 1.000 | ||
| Yes | 1 (11.1) | 18 (11.7) | |
| No | 8 (88.9) | 136 (88.3) | |
| Anticoagulant therapy, n (%) | 1.000 | ||
| Yes | 2 (22.2) | 28 (18.2) | |
| No | 7 (77.8) | 126 (81.8) | |
| Child-Pugh classification, n (%) | 0.775 | ||
| Class A | 7 (77.8) | 134 (87.0) | |
| Class B | 2 (22.2) | 20 (13.0) | |
| INR value, n (%) | 0.064 | ||
| ≥1.5 | 2 (22.2) | 6 (3.9) | |
| <1.5 | 7 (77.8) | 148 (96.1) | |
| PT value, n (%) | 0.022* | ||
| ≤15 s | 5 (55.6) | 136 (88.3) | |
| >15 s | 4 (44.4) | 18 (11.7) | |
TFA, transfemoral access; TACE, transarterial chemoembolization; BMI, body mass index; INR, international normalized ratio; PT, prothrombin time. *, P<0.05.